Literature DB >> 5346697

Staphylocoagulase as a hemostatic agent.

B Mojovic, N Mojovic, M Tager, M C Drummond.   

Abstract

Mesh：

Substances：

Year:  1969        PMID： 5346697      PMCID： PMC2591512     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN： 0044-0086


× No keyword cloud information.
  23 in total

1.  ACTIVATION OF HAGEMAN FACTOR BY SOLUTIONS OF ELLAGIC ACID.

Authors:  O D RATNOFF; J D CRUM
Journal:  J Lab Clin Med       Date:  1964-03

2.  PURIFICATION AND CHARACTERIZATION OF STAPHYLOCOAGULASE.

Authors:  Z ZOLLI; C L SANCLEMENTE
Journal:  J Bacteriol       Date:  1963-09       Impact factor: 3.490

3.  INTRAVASCULAR COAGULATION AND FIBRINOLYSIS BY STAPHYLOCOAGULASE. COMPARISON WITH THROMBIN.

Authors:  J JELJASZEWICZ; S NIEWIAROWSKI; A POPLAWSKI; J PROKOPOWICZ; K WOROWSKI
Journal:  Thromb Diath Haemorrh       Date:  1965-06-15

4.  Purification of staphylococcal coagulase.

Authors:  H BLOBEL; D T BERMAN; J SIMON
Journal:  J Bacteriol       Date:  1960-06       Impact factor: 3.490

5.  Permanent cannulation of aorta and vena cava in rats and ground squirrels.

Authors:  V POPOVIC; P POPOVIC
Journal:  J Appl Physiol       Date:  1960-07       Impact factor: 3.531

6.  [Effects of the injection of staphylocoagulase in rabbits. Attempt to prevent the defibrination syndrome].

Authors:  J P Soulier; O Prou-Wartelle
Journal:  Nouv Rev Fr Hematol       Date:  1967 Sep-Oct

7.  Pharmacology and toxicology of a defibrinating substance from Malayan pit viper venom.

Authors:  A Ashford; J W Ross; P Southgate
Journal:  Lancet       Date:  1968-03-09       Impact factor: 79.321

8.  The effect of ellagic acid on coagulation in vivo.

Authors:  A Girolami; D Agostino; E E Cliffton
Journal:  Blood       Date:  1966-01       Impact factor: 22.113

9.  The isolation and properties of the thrombin-like activity from Ancistrodon rhodostoma venom.

Authors:  M P Esnouf; G W Tunnah
Journal:  Br J Haematol       Date:  1967-07       Impact factor: 6.998

10.  SPECIFIC COAGULASES OF STAPHYLOCOCCUS AUREUS.

Authors:  C H Rammelkamp; M M Hezebicks; J H Dingle
Journal:  J Exp Med       Date:  1950-02-28       Impact factor: 14.307
View more
  4 in total

1.  Intravascular coagulation in mice by the compact-colony-forming active substance (CCFAS) extracted from a strain of Staphylococcus aureus.

Authors:  K Yoshida; T Ohtomo; Y Ichiman; S Narikawa; K Oikawa
Journal:  Br J Exp Pathol       Date:  1981-12

2.  Release of beta-lysin from platelets by thrombin and by a factor produced in heparinized blood.

Authors:  J G Tew; R R Roberts; D M Donaldson
Journal:  Infect Immun       Date:  1974-01       Impact factor: 3.441

3.  RGD delivery of truncated coagulase to tumor vasculature affords local thrombotic activity to induce infarction of tumors in mice.

Authors:  Rana Jahanban-Esfahlan; Khaled Seidi; Hassan Monhemi; Amir Daei Farshchi Adli; Babak Minofar; Peyman Zare; Davoud Farajzadeh; Safar Farajnia; Ramezan Behzadi; Mehran Mesgari Abbasi; Nosratollah Zarghami; Tahereh Javaheri
Journal:  Sci Rep       Date:  2017-08-15       Impact factor: 4.379

4.  NGR (Asn-Gly-Arg)-targeted delivery of coagulase to tumor vasculature arrests cancer cell growth.

Authors:  Khaled Seidi; Rana Jahanban-Esfahlan; Hassan Monhemi; Peyman Zare; Babak Minofar; Amir Daei Farshchi Adli; Davoud Farajzadeh; Ramezan Behzadi; Mehran Mesgari Abbasi; Heidi A Neubauer; Richard Moriggl; Nosratollah Zarghami; Tahereh Javaheri
Journal:  Oncogene       Date:  2018-04-17       Impact factor: 9.867
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.